<VariationArchive RecordType="classified" VariationID="9273" VariationName="NM_000161.3(GCH1):c.3_4dup (p.Glu2fs)" VariationType="Duplication" Accession="VCV000009273" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2016-08-22" MostRecentSubmission="2023-09-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24312" VariationID="9273">
      <GeneList>
        <Gene Symbol="GCH1" FullName="GTP cyclohydrolase 1" GeneID="2643" HGNC_ID="HGNC:4193" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>14q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="54842017" stop="54902826" display_start="54842017" display_stop="54902826" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="55308722" stop="55369541" display_start="55308722" display_stop="55369541" Strand="-" />
          </Location>
          <OMIM>600225</OMIM>
          <Haploinsufficiency last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GCH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GCH1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC130055692" FullName="ATAC-STARR-seq lymphoblastoid silent region 5776" GeneID="130055692" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>14q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="54902541" stop="54903180" display_start="54902541" display_stop="54903180" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000161.3(GCH1):c.3_4dup (p.Glu2fs)</Name>
      <CanonicalSPDI>NC_000014.9:54902659:CC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="54902659" stop="54902660" display_start="54902659" display_stop="54902660" variantLength="2" positionVCF="54902659" referenceAlleleVCF="T" alternateAlleleVCF="TCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="55369377" stop="55369378" display_start="55369377" display_stop="55369378" variantLength="2" positionVCF="55369377" referenceAlleleVCF="T" alternateAlleleVCF="TCC" />
      </Location>
      <ProteinChange>E2fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.55369378_55369379dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.55369378_55369379dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.54902660_54902661dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.54902660_54902661dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008647.1" sequenceAccession="NG_008647" sequenceVersion="1" change="g.5164_5165dup">
            <Expression>NG_008647.1:g.5164_5165dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000161.3" sequenceAccession="NM_000161" sequenceVersion="3" change="c.3_4dup" MANESelect="true">
            <Expression>NM_000161.3:c.3_4dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000152.1" sequenceAccession="NP_000152" sequenceVersion="1" change="p.Glu2fs">
            <Expression>NP_000152.1:p.Glu2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024024.2" sequenceAccession="NM_001024024" sequenceVersion="2" change="c.3_4dup">
            <Expression>NM_001024024.2:c.3_4dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001019195.1" sequenceAccession="NP_001019195" sequenceVersion="1" change="p.Glu2fs">
            <Expression>NP_001019195.1:p.Glu2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024070.2" sequenceAccession="NM_001024070" sequenceVersion="2" change="c.3_4dup">
            <Expression>NM_001024070.2:c.3_4dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001019241.1" sequenceAccession="NP_001019241" sequenceVersion="1" change="p.Glu2fs">
            <Expression>NP_001019241.1:p.Glu2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024071.2" sequenceAccession="NM_001024071" sequenceVersion="2" change="c.3_4dup">
            <Expression>NM_001024071.2:c.3_4dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001019242.1" sequenceAccession="NP_001019242" sequenceVersion="1" change="p.Glu2fs">
            <Expression>NP_001019242.1:p.Glu2fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600225.0003" DB="OMIM" />
        <XRef Type="rs" ID="2140127822" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000161.3(GCH1):c.3_4dup (p.Glu2fs) AND Dystonia 5" Accession="RCV000009855" Version="3">
        <ClassifiedConditionList TraitSetID="2548">
          <ClassifiedCondition DB="MedGen" ID="C1851920">Dystonia 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-04-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-04-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-08-22" MostRecentSubmission="2023-09-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7730309</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2548" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia, DOPA-responsive, with or without hyperphenylalaninemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 5, Dopa-responsive type</ElementValue>
                <XRef ID="Dystonia+5%2C+Dopa-Responsive+Type/2419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dystonia 5</ElementValue>
                <XRef ID="MONDO:0007495" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, progressive, with diurnal variation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia-Parkinsonism with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Segawa syndrome, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, Dopa-responsive, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-GCH1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT5</ElementValue>
                <XRef ID="GTR000288689" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRD</ElementValue>
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12144" />
                <XRef ID="12144" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9817" />
                <XRef ID="9817" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). Initial symptoms are often gait difficulties attributable to flexion-inversion (equinovarus posture) of the foot. Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements. Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur.</Attribute>
                <XRef ID="NBK1508" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301681</ID>
                <ID Source="BookShelf">NBK1508</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="98808" DB="Orphanet" />
              <XRef ID="C1851920" DB="MedGen" />
              <XRef ID="MONDO:0007495" DB="MONDO" />
              <XRef Type="MIM" ID="128230" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30076" SubmissionDate="2016-08-04" DateLastUpdated="2023-09-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600225.0003_DYSTONIA, DOPA-RESPONSIVE" title="GCH1, 2-BP INS_DYSTONIA, DOPA-RESPONSIVE" />
        <ClinVarAccession Accession="SCV000030076" DateUpdated="2023-09-03" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-04-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family with progressive dystonia with marked diurnal fluctuation (128230), Ichinose et al. (1994) identified a heterozygous 2-bp insertion in the GCH1 gene, leading to a frameshift and a premature stop codon at position 197.</Attribute>
              <Citation>
                <ID Source="PubMed">7730309</ID>
              </Citation>
              <XRef DB="OMIM" ID="128230" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1" />
          </GeneList>
          <Name>GCH1, 2-BP INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600225.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DYSTONIA, DOPA-RESPONSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30076" TraitType="Disease" MappingType="Name" MappingValue="DYSTONIA, DOPA-RESPONSIVE" MappingRef="Preferred">
        <MedGen CUI="CN221588" Name="Dopa-responsive dystonia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

